We next examined whether PAR2 activation induces anxiety-like behaviour and/or anhedonia, and given the reduced locomotor activity observed with AC (100 mg kg−1) and its pharmacokinetic profile, we investigated whether AC (10 mg kg−1 i.p.)modulated anxiety-like behaviour and sucrose preference 0.5-h postinjection. Here, F2RL1 is linked to Anxiety.